Literature DB >> 2848452

Further characterization of calpain-mediated proteolysis of the human erythrocyte plasma membrane Ca2+-ATPase.

K K Wang1, B D Roufogalis, A Villalobo.   

Abstract

The membrane-bound form and a solubilized and purified form of the Ca2+-ATPase from human erythrocyte have been proteolyzed under controlled conditions by highly purified Ca2+-dependent neutral cysteine-protease, calpain I, in the absence and in the presence of the calmodulin-calcium complex. In the absence of calmodulin the 136-kDa enzyme was transformed into a group of fragments of 125-124 kDa, followed by the slower formation of a second group of fragments of 82-80 kDa. These heterogeneous fragments were capable of forming an acylphosphate intermediate. The 125- and 82-kDa minor components of each heterogeneous group of fragments (125-124 and 82-80 kDa) were capable of binding calmodulin, whereas the 124- and the 80-kDa major components did not. In the presence of calmodulin, however, the native enzyme was transformed into a 127-kDa fragment followed by the slower formation of an 85-kDa fragment. Both fragments (127 and 85 kDa) formed an acylphosphate intermediate and were capable of binding calmodulin. The presence of calmodulin during calpain action effectively protected the Ca2+-ATPase from proteolytic activation (K.K.W. Wang, A. Villalobo, and B.D. Roufogalis (1988) Arch. Biochem. Biophys. 260, 696-704) and prevented the formation of the calmodulin-insensitive 124- and 80-kDa fragments. Smaller fragments not capable of forming the acylphosphate intermediate were also produced, in particular a 39-37 kDa doublet band retaining the capacity to bind calmodulin. In contrast to the membrane-bound form, the purified form of the Ca2+-ATPase was proteolyzed by calpain at a slower rate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848452     DOI: 10.1016/0003-9861(88)90037-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Structure--function relationship of the human erythrocyte plasma membrane Ca(2+)-ATPase revealed by V8 protease treatment.

Authors:  K K Wang; B D Roufogalis; T H Kuo
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

Review 2.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

3.  N-methyl-D-aspartate receptor-induced proteolytic conversion of postsynaptic class C L-type calcium channels in hippocampal neurons.

Authors:  J W Hell; R E Westenbroek; L J Breeze; K K Wang; C Chavkin; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 4.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis.

Authors:  R Nath; K J Raser; D Stafford; I Hajimohammadreza; A Posner; H Allen; R V Talanian; P Yuen; R B Gilbertsen; K K Wang
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 6.  Ca2+ pumps in smooth muscle cells.

Authors:  L Raeymaekers; F Wuytack
Journal:  J Muscle Res Cell Motil       Date:  1993-04       Impact factor: 2.698

7.  Calpain I activates Ca2+ transport by the reconstituted erythrocyte Ca2+ pump.

Authors:  K K Wang; B D Roufogalis; A Villalobo
Journal:  J Membr Biol       Date:  1989-12       Impact factor: 1.843

Review 8.  The Ca(2+)-transport ATPases from the plasma membrane.

Authors:  F Wuytack; L Raeymaekers
Journal:  J Bioenerg Biomembr       Date:  1992-06       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.